Nová evropská doporučení pro management pacientů vyššího věku s chronickým onemocněním ledvin ve stadiu 3b a vyšším (eGFR < 45 ml/min/1,73 m²)

Czech version

Authors: E. Topinková; V. Teplan
Published in: Geriatrie a Gerontologie 2017, 6, č. 1: 5-15
Category:

Overview

Physicians across discipline see older patients with advanced chronic kidney disease (CKD) and are facing difficult decisions regarding future treatment of these patients including decision if/if not to start dialysis. Therefore we present to Czech readers in a shorter form the recently published European guidelines on management of older patients with advanced CKD stage 3b and higher. New Guidelines focus on 6 problem areas of diagnosis and treatment: (1) estimation of GFR for classification and dose adaptation; (2) prognosticating rate of progression to end-stage renal disease; (3) prognosticating risk of death in medium term periods; (4) assessment of functional status and strategies to improve it; (5) assessment of nutritional status and strategies to improve it; (6) appraisal of benefits and drawbacks of renal replacement therapy versus conservative treatment. Based on thorough evaluation of scientific evidence the recommendations for clinical practice were formed. We do believe that knowledge of CKD differences in seniors will translate into improved medical care for these patients.

Keywords:
Ageing – chronic kidney disease (CKD) 3b and higher – CKD management – frailty – guidelines

Sources

1. Rule AD, Cornell LD, Pogio ED. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 2010; 153: 561–567.

2. Oreopoulos DG, Dimkovic N. Geriatric nephrology is coming of age. J Am Soc Nephrol 2003; 14(4):1099–1101.

3. Teplan V a kol. Nefrologie vyššího věku. MF Praha 2015; 337 s.

4. Levey AS, Coresh J, Green T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766–772.

5. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.

6. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20–29.

7. Farrington K, Covic A, Aucella F, et al. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 ml/min/1.73 m2). Nephrol Dial Transplant 2016 31: ii1–ii66. doi: 10.1093/ndt/gfw356.

8. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089–2100.

9. Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. J Am Med Assoc 2011; 305: 1553–1559.

10. Peeters MJ, van Zuilen AD, van den Brand JA, et al. Validation of the kidney failure risk equation in European CKD patients. Nephrol Dial Transplant 2013; 28: 1773–1779.

11. Tangri N, Grams ME, Levey AS, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. J Am Med Assoc 2016; 315: 164–174.

12. KDIGO. 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013; Suppl 3: 1–150.

13. Pro prognózu dialyzovaných pacientů není rozhodující věk, ale přidružené nemoci. Komentář Dusilová-Sulková S. Postgrad nefrol 2010; 8: 40–41.

14. Bansal N, Katz R, De Boer IH, et al. Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol 2015; 10: 363–371.

15. Thamer M, Kaufman JS, Zhang Y, et al. Predicting early death among elderly dialysis patients: development and validation of a risk score to assist shared decision making for dialysis initiation. Am J Kidney Dis 2015; 66: 1024–1032.

16. McAdams-DeMarco MA, Law A, Salter ML, et al. Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc 2013; 61: 896–901.

17. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J 2005; 173: 489–495.

18. Cheung KL, Montez-Rath ME, ChertowGM, et al. Prognostic stratification in older adults commencing dialysis. J Gerontol A Biol Sci Med Sci 2014; 69: 1033–1039.

19. Couchoud CG, Beuscart JB, Aldigier JC, et al. Development of a risk stratification algorithm to improve patient-centered care and decision making for incident elderly patients with end-stage renal disease. Kidney Int 2015; 88: 1178–1186.

20. Dalrymple LS, Katz R, Rifkin DE, et al. Kidney function and prevalent and incident frailty. Clin J Am Soc Nephrol 2013; 8: 2091–2099.

21. Roshanravan B, Khatri M, Robinson-Cohen C, et al. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 2012; 60: 912–921.

22. Roshanravan B, Robinson-Cohen C, Patel KV, et al. Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol 2013; 24: 822–830.

23. Painter P, Roshanravan B. The association of physical activity and physical function with clinical outcomes in adults with chronic kidney disease. Curr Opin Nephrol Hypertens 2013; 22: 615–623.

24. Heiwe S, Jacobson SH. Exercise training in adults with CKD: a systematic review and meta-analysis. Am J Kidney Dis 2014; 64: 383–393.

25. Painter P, Marcus RL. Assessing physical function and physical activity in patients with CKD. Clin J Am Soc Nephrol 2013; 8: 861–872.

26. Johansson L, Fouque D, Bellizzi V, et al. As we grow old: nutritional considerations for older patients on dialysis. Nephrol Dial Transplant 2016; doi: 10.1093/ndt/gfw201.

27. Ikizler TA, Cano NJ, Franch H, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int 2013; 84: 1096–1107.

28. Moreau-Gaudry X, Jean G, Genet L, et al. A simple protein-energy wasting score predicts survival in maintenance hemodialysis patients. J Ren Nutr 2014; 24: 395–400,

29. Noordzij M, Kramer A, Abad Diez JM, et al. Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA registry annual report. Clin Kidney J 2014; 7: 227–238.

30. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391–398.

31. KDOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Appendix V. Rationale and Methods for the Determination of the Protein Equivalent of Nitrogen Appearance (PNA), 2000. Dostupné z:http://www2.kidney.org.

32. Qunibi WY, Henrich WL. Protein intake in maintenance hemodialysis patients. UpToDate 2016. Dostupné z: http://www.uptodate.com.

33. Johansson L, Fouque D, Bellizzi V, et al. As we grow old: nutritional considerations for older patients on dialysis. Nephrol Dial Transplant 2016; doi: 10.1093/ndt/gfw201.

34. Ikizler TA, Cano NJ, Franch H, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int 2013; 84: 1096–1107.

35. Moreau-Gaudry X, Jean G, Genet L, et al. A simple protein-energy wasting score predicts survival in maintenance hemodialysis patients. J Ren Nutr 2014; 24: 395–400.

36. Noordzij M, Kramer A, Abad Diez JM, et al. Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA registry annual report. Clin Kidney J 2014; 7: 227–238.

37. van Biesen W, van de Luijtgaarden MW, Brown EA, et al. Nephrologists’ perceptions regarding dialysis withdrawal and palliative care in Europe: lessons from a European Renal Best Practice survey. Nephrol Dial Transplant 2015; 30: 1951–1958.

38. Peeters P, Van BiesenW, Veys N, et al. External Validation of a risk stratification model to assist shared decision making for patients starting renal replacement therapy. BMC Nephrol 2016; 17: 41.